Eli Lilly's move to offer lower-priced vials of its obesity drug Zepbound was seen as a step towards expanding patient access. However, some experts raised concerns about the limited doses…
Subscribe Now for Real-time Updates on the Latest Stories!
A recent study published in the Journal of Health Economics has shed light on the detrimental effects of fluoridated community…
GLP-1 drugs like Ozempic have become incredibly popular for their effectiveness in treating diabetes and promoting weight loss. However, a…
UnitedHealth Group's chief executive, Andrew Witty, addressed the public for the first time since the tragic death of one of…
When Donald Trump takes the oath of office today, it may well usher in a new era of Republican messaging…
The healthcare industry is currently facing a crisis of confidence and trust, as evidenced by the recent tragic killing of…
Eli Lilly's move to offer lower-priced vials of its obesity drug Zepbound was seen as a step towards expanding patient…
So, rather than focusing on one specific day as the most depressing of the year, perhaps it’s more helpful to…
Additionally, there’s a lack of understanding around communication and how to communicate effectively with people with disabilities. It’s often assumed…
Sign in to your account